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Summary
Sheehan’s syndrome occurs as a result of ischaemic pituitary necrosis due to severe postpartum haemorrhage. Improvements in
obstetrical care have signiﬁcantly reduced its incidence in developed countries, but postpartum pituitary infarction remains a common
cause of hypopituitarism in developing countries. We report a case of severe postpartum haemorrhage followed by headache, central
diabetes insipidus and failure to lactate, which prompted us to investigate and identify both anterior and posterior pituitary deﬁciency
compatible with Sheehan’s syndrome. A timely diagnosis allowed us to implement an adequate treatment and follow-up plan, which are
known to improve clinical status and patient outcome.
BACKGROUND
Sheehan’s syndrome occurs as a result of ischaemic pituit-
ary necrosis due to severe postpartum haemorrhage.
Improvements in obstetrical care have signiﬁcantly
reduced its incidence in developed countries, but post-
partum pituitary infarction remains a common cause of
hypopituitarism in developing countries.
Acute Sheehan’s syndrome presenting as central dia-
betes insipidus is rare presentation and early recognition is
paramount in improving a patient outcomes.
CASE PRESENTATION
A 45-year-old African-American woman, gravida 2 para 1,
with multiple dichorionic pregnancy, was admitted to the
obstetrics department at 21 weeks gestational age after a
transvaginal ultrasound measurement had showed 10 mm
of cervical length and high risk of preterm delivery. In vitro
fertilisation with oocyte donation had been performed due
to premature ovarian failure and early onset menopause.
She had a history of chronic hypertension, and a previous
full-term delivery with no complications. Her medical and
family history was otherwise unremarkable.
At 26+4 weeks gestation one of the membranes of the
ﬁrst twin was ruptured prematurely, which was managed
conservatively with a course of antenatal corticosteroids
(betamethasone) and antibiotic prophylaxis (ampicillin/
amoxicillin and erythromycin).
At 30 weeks gestation she entered spontaneous labour
and had preterm vaginal delivery, with local anaesthesia
and no other anaesthetic drugs. Live twins were born
weighing 1365g and 1145g (ﬁrst and second, respectively),
both with Apgar score of 9 (10) and 10 (50) without any
major interventions in the delivery room. Both neonates
were admitted to the neonatal care unit for observation
and postnatal care.
Within 1 h of delivery she suffered massive postpartum
bleeding caused by retained placental fragments. Severe
haemodynamic instability ensued, with an estimated
35–40% blood loss. There was need for ﬂuid replacement
(both colloid and crystalloid) and packed red blood
cells. Haemoglobin declined from 13.6 g/dl prepartum to
7.6 g/dl 4 h postpartum (lowest value obtained). The
placental fragments were manually removed followed by
conventional uterine curettage within 2 h after delivery,
and bleeding was controlled.
At about 8 h postpartum she began complaining of
mild headache and photophobia. She had no nausea or
vomiting, abdominal pain or any other symptoms. She
had no history of migraine or headache.
On examination, she was alert and oriented, afebrile,
pulse rate 98 bpm, and blood pressure 133/88 mm Hg. She
was eupnaeic, the bleeding volume per vaginum was within
normal limits and through abdominal palpation the uterus
was contracted ﬁrmly and had approximately the equivalent
of 18 weeks gestational age size. Neurological examination
was unremarkable, including no pupillary changes, and no
focal or meningeal signs.
Laboratory ﬁndings including renal and liver function,
inﬂammatory markers and urinalysis were unrevealing
and excluded pre-eclampsia.
She was started on paracetamol and metamizole with
partial response, and pain slowly abated during the fol-
lowing days. No other symptoms were noted and she was
discharged 5 days after delivery, with both analgesic drugs
and a scheduled appointment within 1 week. Both twins
were still at the neonatal unit with no major morbidity.
By the return visit on day 15 mild non-remitting head-
ache was still persistent, and she was fatigued and had
been unable to breastfeed due to poor milk production.
She had also started noticing excessive thirst (>5 l of
ﬂuids/24 h), polyuria and mild visual disturbance. No
other urinary symptoms were present. There were no psy-
chiatric complaints and there did not seem to be a
primary water-seeking behaviour.
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INVESTIGATIONS
A targeted laboratory work-up including 24 h urinalysis
after 12 h ﬂuid restriction conﬁrmed diuresis of 4.1 l, urine
density 1.003 and urine osmolarity 88 mOsm/kg (simul-
taneous plasma osmolality 288 mOsm/kg). Plasma urea
and creatinine were normal, potassium and calcium levels
were normal and there were no signiﬁcant changes in
other serum laboratory tests. After consulting with the
local endocrinologist an intranasal desmopressin challenge
was performed by day 17. Urine osmolality increased up
to 372 mOsm/kg which established a diagnosis of central
diabetes insipidus (DI).
Basal serum hormonal tests were performed on day 22
postpartum (table 1).
There were low levels of thyroid-stimulating hormone
(TSH) and free thyroxine, cortisol, prolactin and gonado-
tropins, all features suggestive of panhypopituitarism.
The patient was started on intranasally desmopressin
with rapid response and reduction in diuresis.
A CT scan was performed the same day showing dis-
crete enlargement of the right segment of the anterior
pituitary lobe and hypoattenuation after intravenous con-
trast agent use. There were no signiﬁcant sella turcica
ﬁndings, and cerebral and vascular morphology was
normal. MRI a few days later found normal anterior pitu-
itary dimension and morphology, while the posterior pitu-
itary gland was ectopic (infundibular region of the optic
chiasm).
Hormonal stimulation tests were performed on day 42
postpartum at the endocrinology department. Results
conﬁrmed a complete deﬁciency of all pituitary hormones
and reserve (table 2).
DIFFERENTIAL DIAGNOSIS
We considered lymphocytic hypophysitis and pituitary
apoplexy as possible causes of postpartum hypopituitar-
ism. However, imaging ﬁndings did not identify the fea-
tures of any of these diagnoses, that is, respectively
diffuse enlargement with contrast enhancement or a pitu-
itary mass, or pituitary haemorrhage. Our ﬁnal diagnosis
was acute Sheehan’s syndrome presenting as central dia-
betes insipidus.
TREATMENT
The patient was started on replacement treatment for
individual pituitary and downstream hormonal deﬁcien-
cies, which included prednisone (corticotropin and cortisol
deﬁciency), levothyroxine (TSH and thyroxine deﬁciency),
oestrogen-progestin (luteinising hormone (LH), follicle
stimulating hormone (FSH) and oestrogen and progestin
deﬁciency) and desmopressin (antidiuretic hormone deﬁ-
ciency). The patient was not interested in fertility and the
oestrogen–progestin combination was given continuously.
Prolactin deﬁciency has no standard treatment available.
In our setting recombinant growth hormone replacement
is not used routinely for adult-onset deﬁciency. We
instructed the patient regarding the need for stress gluco-
corticoid doses in case of illness, trauma or surgery.
OUTCOME AND FOLLOW-UP
The following year was uneventful and the patient has
been well on replacement therapy. Both newborn twins
were discharged at 37 days postnatal age, with autono-
mous feeding and no relevant morbidity. They were both
doing well at regular follow-up visits with no develop-
mental disabilities.
DISCUSSION
Sheehan’s syndrome occurs as a result of ischaemic pituit-
ary necrosis due to severe postpartum haemorrhage. It
may be rarely seen without massive bleeding or after
normal delivery.1 Pituitary enlargement during pregnancy
causes compression of the superior hypophyseal artery.
Hypotension during delivery may result in arterial spasm
of smaller vessels, apoplexy and subsequent pituitary
necrosis.2
In developed countries postpartum haemorrhage rarely
leads to Sheehan’s syndrome, largely due to improvements
in obstetrical care.3 This case of Sheehan’s syndrome was
diagnosed soon after labour. Most cases have mild hypo-
pituitarism, which may explain delays in recognition up
to years after the inciting event.4 Therefore, it is often
misrecognised and not adequately treated.
The diagnosis of Sheehan’s syndrome is based on a
combination of patient’s history and physical examin-
ation, laboratory tests (including hormone levels and
hormone stimulation tests) and radiologic ﬁndings (prefer-
ably MRI scans). Clinical manifestations of the syndrome
are most often caused by deﬁciencies of hormones of the
anterior pituitary gland.
Involvement of the posterior lobe with central diabetes
insipidus has been rarely described. Two published case
series (n=20 and 28) found no cases of central diabetes
insipidus.5 6 Atmaca et al,7 however, found subtle impair-
ment of neurohypophyseal function on many patients
with Sheehan’s syndrome. The thirst centre might be
Table 1 Basal endocrine parameters, 22 days after delivery
Hormones (Plasma) Units Basal Normal Value
TSH μUI/mL 2.2 0.40–4.00
F T4 ng/dL 0.4 0.8–1.9
ACTH pg/mL 13.3 10–48
Cortisol μg/dL 5 5–25
Prolactin ng/mL 14.2 >20 postpartum
17β Estradiol pg/mL 34 ..
FSH mUI/mL 26 40–200
Na + mEq/L 137 137–145
TSH: thyroid stimulating hormone; FT4: free thyroxine; FT3: free
triiodothyronine; ACTH: corticotropin; FSH: follicle stimulating hormone.
Table 2 Dynamic test, 42 days after delivery
Hormones* (Plasma) Units 0 min 30 min 60 min
TSH μUI/mL 3,5 6,7 5,9
LH mUI/mL 2 4,7 5
FSH mUI/mL 5,5 6,1 6,9
Prolactin ng/mL 5,9 17,7 2,3
GH ng/mL <0,05 <0,05 <0,05
Glucose mg/dL 71 34 57
Cortisol μg/dL 11,7 4 12
*Dynamic tests: Luteinizing hormone-releasing hormone (LHRH) and
Thyrotropin-releasing hormone (TRH) for gonadotrope, prolactine and
thyreotrope axis.
Insulin Hypoglycemia for growth hormone(GH) and corticotropin - cortisol axis.
TSH: thyroid stimulating hormone; LH: luteinizing hormone; FSH: follicle
stimulating hormone.
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affected by ischaemic damage and the osmotic threshold
for the onset of thirst was increased, and 29% patients
had partial central DI. In our case central diabetes insipi-
dus symptoms was paramount in raising suspicion of
Sheehan’s syndrome, although other clinical features of
this syndrome (headache, fatigue, absence of lactation and
amenorrhoea) were also present.
Hyponatremia has been identiﬁed as the most common
electrolyte disturbance, due to volume depletion, cortisol
deﬁciency and hypothyroidism.6 Our patient presented
with borderline low natremia values and no serious symp-
toms, presumably due to an early stage of the disease.
Imaging ﬁndings of the pituitary gland may differ
depending on the stage of the disease. Early CT and MRI
scans usually demonstrate non-haemorrhagic enlargement
of the pituitary gland, which are later followed by its
involution, with an empty sella in late MRIs.1 8 In our
case there were early subtle anterior pituitary CT ﬁndings,
while an ectopic posterior lobe suggested neurohypophy-
sis dysfunction. The latter has been described in speciﬁc
gene-associated congenital hypopituitarism or isolated
hormone deﬁciencies, often accompanied by other cerebral
malformations.9 The history of this case did not suggest
any premorbid hypopituitarism, but it does raise the issue
of possible susceptibility.
In conclusion, we report a case of severe postpartum
haemorrhage followed by headache, central diabetes insi-
pidus and agalactia, which prompted us to investigate and
identify both anterior and posterior pituitary deﬁciency
compatible with Sheehan’s syndrome. A timely diagnosis
allowed us to implement an adequate treatment and
follow-up plan, which are known improve clinical status
and patient outcome.10 11
Learning points
▸ A history of severe postpartum haemorrhage is the key
diagnostic feature.
▸ Classical manifestations include failure to lactate,
amenorrhoea, asthenia, fatigue, headache and
psychiatric disturbances.
▸ Complete central diabetes insipidus is rare, but can
occur.
▸ Treatment of patients with hypopituitarism involves
replacing individual pituitary hormonal deﬁciencies.





1. Keleştimur F. Sheehan’s syndrome. Pituitary 2003;6:181–8.
2. Dejager S, Gerber S, Foubert L, et al. Sheehan’s syndrome: differential
diagnosis in the acute phase. J Intern Med 1998;244:261–6.
3. Feinberg EC, Molitch ME, Endres LK, et al. The incidence of Sheehan’s
syndrome after obstetric hemorrhage. Fertil Steril 2005;84:975.
4. Tessnow AH, Wilson JD. The changing face of Sheehan’s syndrome.
Am J Med Sci 2010;340:402–6.
5. Dökmetaş HS, Kilicli F, Korkmaz S, et al. Characteristic features of 20
patients with Sheehan’s syndrome. Gynecol Endocrinol 2006;22:279.
6. Sert M, Tetiker T, Kirim S, et al. Clinical report of 28 patients with
Sheehan’s syndrome. Endocr J 2003;50:297–301.
7. Atmaca H, Tanriverdi F, Gokce C, et al. Posterior pituitary function in
Sheehan’s syndrome. Eur J Endocrinol 2007;156:563.
8. Dash RJ, Gupta V, Suri S. Sheehan’s syndrome: clinical proﬁle, pituitary
hormone responses and computed sellar tomography. Aust N Z J Med
1993;23:26–31.
9. Tomlinson JW, Holden N, Hills RK, et al. Association between premature
mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study
Group. Lancet 2001;357:425–31.
10. Fujisawa I. Magnetic resonance imaging of the hypothalamic-
neurohypophyseal system. J Neuroendocrinol 2004;16:297–302.
11. Bülow B, Hagmar L, Mikoczy Z, et al. Increased cerebrovascular mortality in
patients with hypopituitarism. Clin Endocrinol (Oxf ) 1997;46:75–81.
BMJ Case Reports 2012; doi:10.1136/bcr-2012-007022 3 of 4
Copyright 2012 BMJ Publishing Group. All rights reserved. For permission to reuse any of this content visit
http://group.bmj.com/group/rights-licensing/permissions.
BMJ Case Report Fellows may re-use this article for personal use and teaching without any further permission.
Please cite this article as follows (you will need to access the article online to obtain the date of publication).
Robalo R, Pedroso C, Agapito A, Borges A. Acute Sheehan’s syndrome presenting as central
diabetes insipidus. BMJ Case Reports 2012;10.1136/bcr-2012-007022, Published XXX
Become a Fellow of BMJ Case Reports today and you can:
▸ Submit as many cases as you like
▸ Enjoy fast sympathetic peer review and rapid publication of accepted articles
▸ Access all the published articles
▸ Re-use any of the published material for personal use and teaching without further permission
For information on Institutional Fellowships contact consortiasales@bmjgroup.com
Visit casereports.bmj.com for more articles like this and to become a Fellow
4 of 4 BMJ Case Reports 2012; doi:10.1136/bcr-2012-007022
